Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11046728 Neuroactive steroids, compositions, and uses thereof

Patent 11046728 was granted and assigned to SAGE Therapeutics on June, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

SAGE Therapeutics

Current Assignee

SAGE Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

110467280

Patent Inventor Names

Albert Jean Robichaud0

Francesco G. Salituro0

Gabriel Martinez Botella0

Boyd L. Harrison0

Date of Patent

June 29, 2021

Patent Application Number

163933960

Date Filed

April 24, 2019

Patent Citations

‌

US Patent 10246482 Neuroactive steroids, compositions, and uses thereof

‌

US Patent 10323059 Neuroactive steroids, compositions, and uses thereof

Patent Citations Received

‌

US Patent 12083131 Neuroactive steroids, compositions, and uses thereof

‌

US Patent 11945836 Compositions and methods for treating CNS disorders

‌

US Patent 12060386 Compositions and methods for treating CNS disorders

Patent Primary Examiner

‌

Golam M. Shameem

Patent abstract

Described herein are neuroactive steroids of the Formula (I):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11046728 Neuroactive steroids, compositions, and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API